Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAllogene Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Allogene Therapeutics, Inc.

$1.71Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $4.64M. Net result −$42.68M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $4.64M. Running result $4.64M. Revenue: $4.64M.
  • Cost of revenue: $0. Running result $4.64M.
  • Gross profit: $4.64M. Running result $4.64M.
  • Research and development: −$30.72M. Running result −$26.08M.
  • General and administrative: −$20.84M. Running result −$46.92M.
  • Impairment of long-lived assets: $0. Running result −$46.92M.
  • Operating income: −$46.92M. Running result −$46.92M.
  • Other income: $4.24M. Running result −$42.68M.
  • Pre-tax loss: −$42.68M. Running result −$42.68M.
  • Income tax benefit: $0. Running result −$42.68M.
  • Net loss: −$42.68M. Running result −$42.68M.